Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Thromboembolism

phorbol 12,13-dibutyrate has been researched along with Thromboembolism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, DS; Hsiao, G; Lin, CH; Lin, KH; Shen, MY; Sheu, JR; Wang, Y1
Chen, TG; Chou, DS; Lee, JJ; Lin, KH; Shen, CH; Sheu, JR1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and Thromboembolism

ArticleYear
Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Experimental biology and medicine (Maywood, N.J.), 2003, Volume: 228, Issue:11

    Topics: Animals; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Humans; In Vitro Techniques; Metallothionein; Mice; Models, Biological; Phorbol 12,13-Dibutyrate; Phosphatidylinositols; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Signal Transduction; Thromboembolism; Thromboxane B2

2003
Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
    The Chinese journal of physiology, 2007, Jun-30, Volume: 50, Issue:3

    Topics: Blood Platelets; Caffeic Acids; Cell Adhesion Molecules; Cyclic AMP; Cyclic GMP; Humans; Microfilament Proteins; Phenylethyl Alcohol; Phorbol 12,13-Dibutyrate; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Thromboembolism

2007